|Bid||50.27 x 200|
|Ask||50.39 x 100|
|Day's Range||48.13 - 50.65|
|52 Week Range||18.90 - 50.65|
|PE Ratio (TTM)||42.85|
|Dividend & Yield||0.80 (1.67%)|
|1y Target Est||N/A|
Thermo Fisher Scientific (TMO) continues to gain considerable synergies from FEI Company acquisition. A raised guidance buoys optimism.
Categories: Yahoo FinancePetMed Express, Inc. relative valuation is OVERVALUED and it has a fundamental analysis score of 78. Our analysis is based on comparing PetMed Express, Inc. with the following peers – Rite Aid Corporation, PharMerica Corporation, China Jo-Jo Drugstores, Inc., Walgreens Boots Alliance Inc and CVS Health Corporation (RAD-US, PMC-US, CJJD-US, WBA-US and CVS-US). PetMed Express, ... Read more (Read more...)
PetMed (PETS) initiated fiscal 2018 with better-than-expected results in the first quarter, beating both earnings and revenues.